Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Hardy

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
BMC Medicine|December 31, 2015
A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related toxicitiesJean E Abraham, Louise Hiller, Leila Dorling, et al.
European Journal of Cancer (Oxford, England : 1990)|January 22, 2014
Capecitabine and streptozocin ± cisplatin in advanced gastroenteropancreatic neuroendocrine tumoursTim Meyer, Wendi Qian, Martyn E Caplin, et al.
Plos One|July 9, 2016
The Relationship between Common Genetic Markers of Breast Cancer Risk and Chemotherapy-Induced Toxicity: A Case-Control StudyLeila Dorling, Siddhartha Kar, Kyriaki Michailidou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2014
Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with PaclitaxelJean E Abraham, Qi Guo, Leila Dorling, et al.
Scientific Data|September 11, 2023
A high-resolution daily global dataset of statistically downscaled CMIP6 models for climate impact analysesSolomon Gebrechorkos, Julian Leyland, Louise Slater, et al.
Nature Communications|May 13, 2025
Neoadjuvant PARP inhibitor scheduling in BRCA1 and BRCA2 related breast cancer: PARTNER, a randomized phase II/III trialJean E Abraham, Lenka Oplustil O'Connor, Louise Grybowicz, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
BMC Medicine|December 31, 2015
A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related toxicitiesJean E Abraham, Louise Hiller, Leila Dorling, et al.
European Journal of Cancer (Oxford, England : 1990)|January 22, 2014
Capecitabine and streptozocin ± cisplatin in advanced gastroenteropancreatic neuroendocrine tumoursTim Meyer, Wendi Qian, Martyn E Caplin, et al.
Plos One|July 9, 2016
The Relationship between Common Genetic Markers of Breast Cancer Risk and Chemotherapy-Induced Toxicity: A Case-Control StudyLeila Dorling, Siddhartha Kar, Kyriaki Michailidou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2014
Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with PaclitaxelJean E Abraham, Qi Guo, Leila Dorling, et al.
Scientific Data|September 11, 2023
A high-resolution daily global dataset of statistically downscaled CMIP6 models for climate impact analysesSolomon Gebrechorkos, Julian Leyland, Louise Slater, et al.
Nature Communications|May 13, 2025
Neoadjuvant PARP inhibitor scheduling in BRCA1 and BRCA2 related breast cancer: PARTNER, a randomized phase II/III trialJean E Abraham, Lenka Oplustil O'Connor, Louise Grybowicz, et al.
Pageof 2